Go Capital

Go Capital is a management company based in Rennes, France, established in 2003. It is approved by the AMF and is a member of AFIC. The firm focuses on managing over 130 million in assets, primarily investing in early-stage innovative companies with high growth potential in western France.

Mohamed Abdesslam

Investment Director

Alexandre Boulay

Investment Associate

Clementine Breysse

Investment Associate

Eric Cozanet

President

Emmanuelle Deponge

Venture Partner

Bertrand Distinguin

President

Tristan Garde

Investment Associate

Jerome Gueret

CEO

Frédéric Le Guillou

Investor

Jean Marc Herbert

Venture Partner

Aude Kermarrec

Administrative and Financial Director

David Leray

Investor

Mathieu Quéguiner

Investment Associate

Past deals in Southern Europe

Expliseat

Venture Round in 2023
Expliseat combines innovation and manufacturing performance in the lightest aircraft seat in the world: the Titanium Seat. At just 4 kg, this seat reduces fuel consumption considerably, resulting in savings of up to $500,000 per plane per year. And with 10 patents, the Titanium Seat also provides passengers with greater comfort and 2 inches more room, thanks to its unique ergonomic design.

Graftys

Venture Round in 2022
Graftys, an Aix-en-Provence, France-based early stage company focused on advanced bone biologics.

Pubstack

Series A in 2022
Pubstack is an internet company that collects, processes, and visualize events per day. It delivers a product that customers love, they tackle and solve complex technical problems at scale, using the cloud and today’s best open source technologies.

Secure-IC

Venture Round in 2022
Secure-IC is a spin-off from Télécom ParisTech University, one of the most advanced institutes in embedded security research. Sylvain Guilley, Jean-Luc Danger and Laurent Sauvage, Paris Tech researchers and inventors of more than 50 families of patents on embedded security have founded Secure-IC jointly with Hassan Triqui and Philippe Nguyen in january 2010.

Aurora Cold Plasma Sterilisation

Venture Round in 2021
Aurora Cold Plasma Sterilization manufactures medical device sterilizers that use cold plasma. They are the developers of sterilizers intended for the cold sterilization of fragile or complex medical devices. They offer plasma sterilizing devices based on low-pressure air-gas plasma generation. They are involved in the field of sterilization and are supported by committed investors, shareholders, and partners.

Shopopop

Funding Round in 2021
Shopopop is a collaborative delivery platform that facilitates the connection between individuals looking to deliver groceries and those in need of home delivery services. The platform allows users to turn their daily journeys into profitable opportunities by delivering items for others in exchange for a small fee. By linking vendors with customers, Shopopop aims to streamline the process of grocery delivery, ensuring that users receive their purchases conveniently at home without complications. This innovative approach not only enhances local commerce but also promotes a shared economy, benefiting both deliverers and recipients.

Horama SAS

Series B in 2021
Horama SAS is a biotechnology company based in Paris, France, established in 2014. It specializes in developing gene therapy products aimed at treating rare ophthalmic diseases, particularly targeting inherited retinal dystrophies and retinopathies. By utilizing recombinant adeno-associated viral vectors, Horama's therapies aim to deliver a functional copy of mutated genes to affected retinal cells. This approach seeks to restore normal cell function, prevent further deterioration of vision, and ultimately improve or restore visual capabilities for patients. The company is positioning itself as a significant player in the ophthalmic gene therapy sector, with the goal of enhancing patient autonomy while also contributing to reduced healthcare costs.

Diafir

Venture Round in 2021
Diafir develops and manufactures biological testing systems that utilize unique infrared fiber sensor technology for rapid biological analysis. Founded in 2011 and based in Rennes, France, the company focuses on in situ analytical tools that serve key applications in point-of-care medical diagnostics, food analysis, and the monitoring of organic chemical reactions. Diafir's systems are designed to quickly detect conditions such as chronic liver disease, infections, and tumors, achieving results in as little as five minutes. The company's innovative approach leverages chalcogenide fiberglass, enabling effective infrared light transmission for precise and efficient biological analysis.

SWEETCH Energy

Venture Round in 2021
SWEETCH Energy is developing a breakthrough technology in the field of salinity gradient power harvesting.

Velco

Venture Round in 2021
Velco SAS, founded in 2015 and based in Nantes, France, specializes in mobile applications that enhance bicycle security and navigation. The company's flagship product, Wink, is a handlebar device that connects to smartphones, enabling users to track their rides and prevent bike theft. In addition to security features, Velco aims to improve urban mobility by offering solutions that facilitate the movement of people and goods, contributing to a more efficient and harmonious urban environment.

Velco

Venture Round in 2020
Velco SAS, founded in 2015 and based in Nantes, France, specializes in mobile applications that enhance bicycle security and navigation. The company's flagship product, Wink, is a handlebar device that connects to smartphones, enabling users to track their rides and prevent bike theft. In addition to security features, Velco aims to improve urban mobility by offering solutions that facilitate the movement of people and goods, contributing to a more efficient and harmonious urban environment.

Nextflow Software

Series A in 2020
Nextflow Software operates as an industry specific independent software vendor. It develops and sells computer – aided engineering software in the field of computations fluid dynamic (CFD). Its solution includes ditching and sloshing to aeronautic industry; fording river crossing, gearbox lubrication, hydroplaning, rain on windshield and sloshing to automotive industry; dam break and flooding solutions to energy & environment industry; drilling solutions to industrial processes; ship resistance, wave impact loads and sloshing to marine & offshore industry. Its product includes studio and solvers. Nextflow Software was founded in 2015 and is based in Nantes, France.

VitaDX

Venture Round in 2020
VitaDX International SA, founded in 2009 and based in Rennes, France, specializes in the early diagnosis of bladder cancer. The company leverages artificial intelligence and fluorescence imaging technology to enhance diagnostic accuracy. Its primary product, VisioCyt®, allows for bladder cancer detection through a simple urine sample, improving upon traditional urinary cytology methods. By utilizing advanced imaging and machine learning techniques, VitaDX's solutions enable pathologists and healthcare providers to identify potential bladder abnormalities early, facilitating timely diagnosis and treatment, which can lead to better patient outcomes.

ABC Transfer

Series A in 2020
ABC Transfer is a biopharmaceutical company that specializes in the development of Rapid Transfer Systems (RTS) for the pharmaceutical industry. The company manufactures secure transfer systems designed specifically for sterile drug manufacturing and bioprocessing. Its innovative solutions include alpha doors, beta containers, and single-use bags, all built on patented designs. These systems enhance sterility assurance, improve operator safety, and increase overall efficiency in drug manufacturing processes. Through its focus on secure and efficient transfer methods, ABC Transfer aims to support the biopharmaceutical industry's critical need for reliable and safe drug production.

Quortex

Seed Round in 2020
Quortex develops artificial intelligence based software solution that will lower the infrastructural and network costs for content delivery over the internet. The company was incorporated in 2018 and is based in Cesson-Sévigné, France.

Energiency

Series A in 2020
Energiency is SaaS platform to assess and manage energy performance industrial environment.

Aviwest

Series B in 2020
Aviwest SAS develops and markets digital video equipment and solutions for broadcast and security markets. Its products include digital mobile news gathering wireless camera systems that allow broadcasters, content producers, and TV stations to produce professional live video contents, such as breaking news, live shows, and interviews from remote places; and digital audio and video compression boards. The company also provides training, installation, validation, customer support, and maintenance services. Its products are used in digital television and news gathering, and surveillance markets, as well as in military unmanned vehicles and robots. The company was founded in 2008 and is based in Rennes, France.

Shopopop

Venture Round in 2020
Shopopop is a collaborative delivery platform that facilitates the connection between individuals looking to deliver groceries and those in need of home delivery services. The platform allows users to turn their daily journeys into profitable opportunities by delivering items for others in exchange for a small fee. By linking vendors with customers, Shopopop aims to streamline the process of grocery delivery, ensuring that users receive their purchases conveniently at home without complications. This innovative approach not only enhances local commerce but also promotes a shared economy, benefiting both deliverers and recipients.

Robocath

Venture Round in 2019
Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical procedures safer, thanks to reliable technologies, while complementing manual interventions. R-One™ is the first solution developed by Robocath. It uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. It is designed to operate with precision and perform specific movements creating better interventional conditions. Thanks to its open architecture, R-One™ is compatible with market leading devices and cath labs. Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all.

Abyss Ingredients

Seed Round in 2019
Abyss' Ingredients manufactures marine biotechnological ingredients that provides nutrients for infants, children, and adults. The company’s products are used for joints health, metabolic syndrome, anti-inflammatory, cardiovascular protection, digestive health, immunomodulatory, skin health, and brain health. It serves customers in France and internationally. The company was incorporated in 2004 and is based in Caudan, France with locations in Quimper and Lorient, France.

Igyxos

Series A in 2019
Igyxos’ mission is to develop innovative new pharmaceuticals and medical technologies in the field of human fertility. Igyxos is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds such as small molecules and antibodies, and the acquisition of intellectual property rights to drugs and technologies that can then be brought to the development phase. Igyxos also support the transfer of potential drug candidates to pre-clinical and clinical phases of drug development.

Graftys

Series A in 2019
Graftys, an Aix-en-Provence, France-based early stage company focused on advanced bone biologics.

Monemprunt

Seed Round in 2018
Monemprunt.com is a digital brokerage firm specializing in real estate credit, founded in 2016 and based in Rennes, France. The platform operates as a direct exchange between borrowers and banks, offering a streamlined and online process for securing competitive loan rates. Monemprunt.com aims to simplify the mortgage application journey by providing borrowers with the tools and advice needed to manage their loan applications independently. The firm negotiates favorable terms on behalf of its clients, ensuring a faster response time and centralized information to aid decision-making. Catering to both individuals and professionals, Monemprunt.com addresses the evolving needs of a tech-savvy clientele seeking efficient financing solutions for their real estate projects.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Shopopop

Venture Round in 2018
Shopopop is a collaborative delivery platform that facilitates the connection between individuals looking to deliver groceries and those in need of home delivery services. The platform allows users to turn their daily journeys into profitable opportunities by delivering items for others in exchange for a small fee. By linking vendors with customers, Shopopop aims to streamline the process of grocery delivery, ensuring that users receive their purchases conveniently at home without complications. This innovative approach not only enhances local commerce but also promotes a shared economy, benefiting both deliverers and recipients.

Velco

Venture Round in 2018
Velco SAS, founded in 2015 and based in Nantes, France, specializes in mobile applications that enhance bicycle security and navigation. The company's flagship product, Wink, is a handlebar device that connects to smartphones, enabling users to track their rides and prevent bike theft. In addition to security features, Velco aims to improve urban mobility by offering solutions that facilitate the movement of people and goods, contributing to a more efficient and harmonious urban environment.

Tricares

Series B in 2018
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

ideolys

Venture Round in 2018
Ideolys SAS provides Web-based software solutions for catering businesses. The company offers Easilys, an Internet application for the management of B&I, education, and healthcare catering operations; and Easilys Commandes Convives, a customer’s portal for central kitchen’s remote sites and home deliveries. It also provides training, support, hosting, and project management services. Ideolys SAS was founded in 2010 and is based in La Roche sur Yon, France.

Vite Mon Marché

Seed Round in 2018
Vite Mon Marché offers urban / Nantes delivery in less than one hour of fresh and local products directly to the home (fruit, vegetables, meat, fish, dairy, drinks ...). Discovered from producers in the outskirts of Nantes, hundreds of fresh and high quality farm produce (organic or not) are offered every day of the week.

Turbotech

Venture Round in 2018
TURBOTECH S.A.S develops energy storage system for aircraft. The company offers turboprops and turbo electric generators for light aircraft which combines recuperated turbine with electric machine. The company was founded in 2017 and is headquartered in Toussus-Le-Noble, France.

Biosency

Seed Round in 2018
BIOSENCY SAS designs and manufactures medical devices. The company manufactures PPG sensor system that monitors and prevents solution dedicated to respiratory insufficiency. It measures cardio-respiratory parameters at rest and in outpatient efforts. The device provides telemonitoring, prediction, prevention of respiratory insufficiency, and facilitates clinical management. BIOSENCY SAS was founded in 2017 and is based in Cesson-Sévigné, France.

Pherecydes Pharma

Series B in 2018
Pherecydes Pharma SA engages in the research and development of lytic bacteriophages for therapeutic and diagnostic applications with a focus on antibiotic resistance. It develops several banks of bacteriophages, including the collection of phages against Escherichia coli. The company was incorporated in 2006 and is based in Romainville, France.

BodyCap

Series A in 2017
BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

Seaver

Seed Round in 2017
Seaver SAS develops connected girth products for monitoring horse health and performance. The girth worn by the horse provides owners and coaches with data on heart and respiratory rate, calories, gait, and jump. The company offers connected devices for the equestrian industry. It also develops a mobile application to monitor and track data collected form the girth. Seaver SAS was founded in 2016 and is based in Caen, France.

Horama SAS

Series B in 2017
Horama SAS is a biotechnology company based in Paris, France, established in 2014. It specializes in developing gene therapy products aimed at treating rare ophthalmic diseases, particularly targeting inherited retinal dystrophies and retinopathies. By utilizing recombinant adeno-associated viral vectors, Horama's therapies aim to deliver a functional copy of mutated genes to affected retinal cells. This approach seeks to restore normal cell function, prevent further deterioration of vision, and ultimately improve or restore visual capabilities for patients. The company is positioning itself as a significant player in the ophthalmic gene therapy sector, with the goal of enhancing patient autonomy while also contributing to reduced healthcare costs.

Wexity

Seed Round in 2017
Wexity is a company that specializes in developing urban management solutions tailored for small and medium-sized cities. Founded in 2017 and based in Nantes, France, Wexity offers a digital city management platform designed to assist local government officials in addressing the complex challenges of urbanization. The platform facilitates investment planning, evaluates the impacts of growth forecasts, and assesses climate and industrial risks. By analyzing urban data, Wexity provides insights into environmental and infrastructure impacts, helping city executives to create prevention plans and generate comprehensive reports. With a focus on high-growth regions such as Africa, India, and the Middle East, Wexity aims to deliver affordable and user-friendly solutions to support effective city management as urban populations continue to rise.

VitaDX

Seed Round in 2017
VitaDX International SA, founded in 2009 and based in Rennes, France, specializes in the early diagnosis of bladder cancer. The company leverages artificial intelligence and fluorescence imaging technology to enhance diagnostic accuracy. Its primary product, VisioCyt®, allows for bladder cancer detection through a simple urine sample, improving upon traditional urinary cytology methods. By utilizing advanced imaging and machine learning techniques, VitaDX's solutions enable pathologists and healthcare providers to identify potential bladder abnormalities early, facilitating timely diagnosis and treatment, which can lead to better patient outcomes.

Robocath

Venture Round in 2017
Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical procedures safer, thanks to reliable technologies, while complementing manual interventions. R-One™ is the first solution developed by Robocath. It uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. It is designed to operate with precision and perform specific movements creating better interventional conditions. Thanks to its open architecture, R-One™ is compatible with market leading devices and cath labs. Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all.

SWEETCH Energy

Venture Round in 2017
SWEETCH Energy is developing a breakthrough technology in the field of salinity gradient power harvesting.

ComparateurAgricole.com

Series A in 2017
ComparateurAgricole.com aims to valorize farmers' stocks by offering the best prices in cereals (wheat, barley, corn ...) and oilseeds (rapeseed). The activity has extended to the supply of fertilizers following the demand of the farmers customers, always with the objective to guarantee the best quality / price ratio. All prices are transparent and accessible in a few clicks. The headquarters of the company is located on the family farm in GOHORY. We made the choice to stay in Beauce, granary of France, to be close to our farmers. For several months, the offices are located in Chartres, in the city of innovation, an innovative business incubator.

I-Sep

Venture Round in 2017
i-SEP is a French Medtech specializing in auto-transfusion and the Patient Blood Management. i-SEP has developed a completely innovative technology for the separation of blood components. Our ambition is to become the first French start-up to market a self-transfusion system capable of recovering both red blood cells and platelets during hemorrhagic surgical procedures. i-SEP works in close collaboration with the surgical teams of reference with missions to improve the patient benefit, simplify the work of practitioners and help reduce hospital costs.

SurfactGreen

Venture Round in 2017
Surfact'Green is a company that specializes in the development and production of patented ecological surfactants derived from agro-resources such as algae and sugar beet co-products. Established as a business unit in 2011 at the Rennes National School of Chemistry, it builds on over a decade of research conducted by the Organic and Supramolecular Chemistry team. The company focuses on creating green chemistry solutions that replace products derived from petrochemistry with eco-compatible, biodegradable alternatives. Surfact'Green's surfactants are formulated to be solvent-free, sulfate-free, and readily biodegradable, allowing businesses to reduce their environmental and human health impacts. The company collaborates with various public and private laboratories, as well as industrial partners, to advance its innovations in sustainable surfactant production.

Energiency

Series A in 2017
Energiency is SaaS platform to assess and manage energy performance industrial environment.

QOS Energy

Venture Round in 2017
QOS ENERGY operates as a software vendor that specializes in energy management systems. The company develops and commercializes Qantum, a Software-as-a-Service solution for the monitoring and management of renewable energy infrastructures. It serves the specific requirements of professional energy performance managers, including medium and large size photovoltaic, wind, hydraulic, and biogas plants; energy efficiency in buildings and industry; and eco-territories and smartgrid projects of various sizes in Europe. The company was founded in 2010 and is based in La Chapelle sur Erdre, France with an additional office in the United Kingdom. QOS ENERGY operates as a subsidiary of The Astelia Group.

Malkyrs

Venture Round in 2016
Malkyrs Studio offers the opportunity to play a game of physical cards retaining the improvements acquired during the dematerialization of the game on the Internet while enjoying the virtues of the traditional board game. Thus it was possible for us to imagine a game of cards before any physical but proposing an unprecedented digital interaction enriching the experience of the players.

EasyBroadcast

Seed Round in 2016
EasyBroadcast is a company based at the Ecole Centrale de Nantes, a SAAS software editor that optimizes the bandwidth consumed by streaming audio and video content providers (VOD, SVOD and internet service using video). .

Sabella

Venture Round in 2016
Sabella SAS is an engineering and project management firm based in Quimper, France, specializing in marine energies. Founded in 2008, the company develops submarine tidal stream turbines designed to generate hydrokinetic energy. Sabella supplies reliable turnkey energy solutions worldwide, focusing on a differentiated and economically optimized range of technologies. These innovations are protected by patents and aim to support a new energy model specifically for remote grids on islands and isolated coastal communities.

InFlectis BioScience

Series A in 2016
InFlectis BioScience is a drug discovery company based in Nantes, France, established in 2013. The company specializes in developing small molecule drugs that target the unfolded protein response, aiming to address misfolded protein disorders linked to neurodegenerative and age-related diseases. By focusing on the cellular defense system against misfolded proteins, InFlectis BioScience seeks to modulate key proteins involved in maintaining endoplasmic reticulum (ER) proteostasis, which is essential for cellular function and survival. The company’s innovative approach helps to safeguard cellular integrity by managing ER stress, a condition that arises when the folding capacity of the ER is compromised. Through its research and development efforts, InFlectis BioScience strives to advance preclinical-stage products that can enhance patient care while maximizing the commercial potential of its offerings.

Kemwatt SAS

Private Equity Round in 2016
Kemwatt SAS designs, develops, manufactures, and markets batteries with circulating electrolytes for application in stationary storage of electricity to facilitate the management of the network within the framework of renewable electrical production.

Dictanova

Venture Round in 2016
Founded in 2011 by Fabien Poulard (PhD in Computer Science, automated language processing), Dictanova has developed a cloud based platform that provides text analytics and sentiment analysis services, for all companies who need to understand their customers. This platform allows marketing and customer experience professionals to explore and analyze thousand of client feedbacks in a few minutes. Customer feedback analysis provides keys to understand clients needs, and identify the subjects of tension in the customer experience as well as the delighting factors.

I-Sep

Seed Round in 2015
i-SEP is a French Medtech specializing in auto-transfusion and the Patient Blood Management. i-SEP has developed a completely innovative technology for the separation of blood components. Our ambition is to become the first French start-up to market a self-transfusion system capable of recovering both red blood cells and platelets during hemorrhagic surgical procedures. i-SEP works in close collaboration with the surgical teams of reference with missions to improve the patient benefit, simplify the work of practitioners and help reduce hospital costs.

Alcuin

Funding Round in 2015
Alcuin SAS specializes in developing software solutions for talent and training management. The company offers human capital management tools that encompass talent assessments, internal mobility and recruitment portals, performance reviews, training plan development, compensation management, career planning, and strategic workforce planning. Its clientele spans various sectors, including services, banking, insurance, industry, health, transport, energy, media, and the public sector. In addition to these solutions, Alcuin provides corporate learning management systems that cover aspects such as sales management, training portfolios, session enrollments, and verification of learning. The company also addresses the needs of higher education institutions through its campus learning management solutions, which facilitate program design, admissions, accreditation, and billing for tuition. Founded in 2013 and headquartered in Beaucouzé, France, with an office in Paris, Alcuin serves both mid-sized and large corporations in France and internationally. As of December 2020, it operates as a subsidiary of Total Specific Solutions.

Ergosup

Series A in 2015
Ergosup is a company based in Malataverne, France, that specializes in the development of decentralized hydrogen-energy production systems. The firm has created an innovative process for producing high-pressure hydrogen on-site, which facilitates the refueling of hydrogen fuel vehicles. Ergosup provides generators that store and convert electricity into hydrogen under pressure, enabling the co-generation of electric power for hydrogen service stations and various industrial applications. This technology allows clients to achieve zero-emission solutions for mobility applications, contributing to a more sustainable energy future.

Qowisio

Venture Round in 2015
Qowisio SAS is an IoT solution provider based in Angers, France, with additional offices in Austin, Texas, and Paris. Founded in 2009, the company specializes in low-cost, low-power cellular networks for IoT applications, focusing on low-bandwidth connectivity for wireless devices. Qowisio offers a diverse range of connected devices and technological solutions tailored to various use cases, including tracking, power monitoring, environment monitoring, security monitoring, pallet tracking, and temperature monitoring for buildings and commercial refrigerators. Its products are designed to enhance productivity and enable clients, including small to medium-sized businesses and larger enterprises, to create new revenue streams through improved connectivity and data integration.

VitamFero

Series C in 2015
VitamFero SA, a biotechnology company, designs, develops, registers, and markets prophylactic agents such as vaccines and neonatal immunostimulants for the treatment of various infectious diseases using Toxo Mic1-3KO. It offers vaccines, such as VFOtx-251, VFOne-273 and VFOlh-211 for the treatment of ovine toxoplasmosis, bovine neosporosis, canine leishmaniasis, and equine protozoal myeloencephalitis (EPM) respectively. The company was founded in 2005 and is based in Angers, France.

Digitaleo

Venture Round in 2015
Digitaleo provides digital marketing solutions to merchants and retail chains. It collects and uses the data of their customers to allow outlets to better manage their traffic and act in real time on their turnover. Digitaleo specializes in email marketing, CRM, e-commerce, and more. it was launched in 2004 and is based in Rennes, Bretagne.

EffiNov Laboratory

Venture Round in 2015
EffiNov Nutrition S.A.S. manufactures vitamin supplements. The company also develops and markets diet programs based on software nutritional analysis. It offers food and nutrition plans for deterioration of general state, digestive disorders, emotional stress, sleep disorders, joint pains, weight loss, and pregnancy. The company was founded in 2010 and is based in Lorient, France.

Qivivo

Venture Round in 2015
QIVIVO is an energy savings provider. Our mission is to help households to regain control of their energy bills. Heating accounts for 65% of the energy bill and we found that temperature of a home can be optimized 35% of the time without degradation of comfort. We provide, therefore, the temperature of the comforts of home cheaper. Through such a box connected to the heating, Qivivo program automatically adjusts the ideal heating for every home.

Diafir

Venture Round in 2015
Diafir develops and manufactures biological testing systems that utilize unique infrared fiber sensor technology for rapid biological analysis. Founded in 2011 and based in Rennes, France, the company focuses on in situ analytical tools that serve key applications in point-of-care medical diagnostics, food analysis, and the monitoring of organic chemical reactions. Diafir's systems are designed to quickly detect conditions such as chronic liver disease, infections, and tumors, achieving results in as little as five minutes. The company's innovative approach leverages chalcogenide fiberglass, enabling effective infrared light transmission for precise and efficient biological analysis.

InFlectis BioScience

Seed Round in 2015
InFlectis BioScience is a drug discovery company based in Nantes, France, established in 2013. The company specializes in developing small molecule drugs that target the unfolded protein response, aiming to address misfolded protein disorders linked to neurodegenerative and age-related diseases. By focusing on the cellular defense system against misfolded proteins, InFlectis BioScience seeks to modulate key proteins involved in maintaining endoplasmic reticulum (ER) proteostasis, which is essential for cellular function and survival. The company’s innovative approach helps to safeguard cellular integrity by managing ER stress, a condition that arises when the folding capacity of the ER is compromised. Through its research and development efforts, InFlectis BioScience strives to advance preclinical-stage products that can enhance patient care while maximizing the commercial potential of its offerings.

BodyCap

Venture Round in 2015
BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

QOS Energy

Venture Round in 2014
QOS ENERGY operates as a software vendor that specializes in energy management systems. The company develops and commercializes Qantum, a Software-as-a-Service solution for the monitoring and management of renewable energy infrastructures. It serves the specific requirements of professional energy performance managers, including medium and large size photovoltaic, wind, hydraulic, and biogas plants; energy efficiency in buildings and industry; and eco-territories and smartgrid projects of various sizes in Europe. The company was founded in 2010 and is based in La Chapelle sur Erdre, France with an additional office in the United Kingdom. QOS ENERGY operates as a subsidiary of The Astelia Group.

VitamFero

Funding Round in 2014
VitamFero SA, a biotechnology company, designs, develops, registers, and markets prophylactic agents such as vaccines and neonatal immunostimulants for the treatment of various infectious diseases using Toxo Mic1-3KO. It offers vaccines, such as VFOtx-251, VFOne-273 and VFOlh-211 for the treatment of ovine toxoplasmosis, bovine neosporosis, canine leishmaniasis, and equine protozoal myeloencephalitis (EPM) respectively. The company was founded in 2005 and is based in Angers, France.

Atlanthera

Venture Round in 2014
Atlanthera is a research and development company focused on innovative therapeutic strategies for treating bone tumors and metastases. It has developed a drug discovery platform that utilizes new chemical molecules designed to target bone tissue specifically. This platform allows for the vectorization of active pharmaceutical ingredients, enabling the precise delivery of high concentrations of these molecules directly to bone tumors. By concentrating treatment locally, Atlanthera aims to minimize systemic adverse effects, offering healthcare professionals novel options for managing bone tumor-related conditions.

Aqualeg

Seed Round in 2013
Aqualeg is a company has invented and produces skin-friendly silicone leg prosthesis liners that allow patients to use water in the water, unlike all existing skincare products.

BodyCap

Venture Round in 2013
BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

Carlina Technologies

Equity Crowdfunding in 2012
Carlina Technologies is a biotechnology company based in Angers that specializes in the development of micro and nanomedicines using innovative encapsulation processes of small molecules and therapeutic proteins. Carlina, born of the rapprochement between Professor Jean-Pierre Benoit, director of the unit INSERM 1066 (laboratory of Micro and Nanomedecines Biomimetics), and of Olivier Meyer, doctor in Pharmaceutical Sciences of the University of Paris XI, is laureate 2010 national competition to help start up innovative technologies.

EffiNov Laboratory

Seed Round in 2012
EffiNov Nutrition S.A.S. manufactures vitamin supplements. The company also develops and markets diet programs based on software nutritional analysis. It offers food and nutrition plans for deterioration of general state, digestive disorders, emotional stress, sleep disorders, joint pains, weight loss, and pregnancy. The company was founded in 2010 and is based in Lorient, France.

Diafir

Seed Round in 2012
Diafir develops and manufactures biological testing systems that utilize unique infrared fiber sensor technology for rapid biological analysis. Founded in 2011 and based in Rennes, France, the company focuses on in situ analytical tools that serve key applications in point-of-care medical diagnostics, food analysis, and the monitoring of organic chemical reactions. Diafir's systems are designed to quickly detect conditions such as chronic liver disease, infections, and tumors, achieving results in as little as five minutes. The company's innovative approach leverages chalcogenide fiberglass, enabling effective infrared light transmission for precise and efficient biological analysis.

Neosteo

Seed Round in 2012
Neosteo SAS is a French company based in Nantes that specializes in the design and production of advanced implant technologies and instrument kits for orthopedic surgery. Founded in 2010, Neosteo focuses on developing innovative solutions aimed at simplifying osteotomy and trauma surgeries. Their product offerings include FlexitSystem plates for knee osteotomy, as well as a range of implant technologies and kits designed for high tibial osteotomy and femoral osteotomy procedures. These kits comprise osteosynthesis plates, locking screws, surgical guides, and other essential instruments, facilitating efficient surgical practices and promoting immediate post-operative recovery for patients.

La société LENTILLES

Seed Round in 2011
The company LENTILLES (LCS) is a laboratory specialized in contactology. The Caen-based company has developed a patented process for producing hybrid contact lenses (using flexible polymers and rigid polymers). Laboratoire LCS is a French contact lens manufacturing laboratory , located in Normandy. LCS services a variety of vision needs and supplies ophthalmologists and opticians with a wide range of tailor made rigid and soft lenses.

Neli Technologies

Series B in 2010
NELI Technologies is developing a solution for broadcasting digital terrestrial television throughout the home using powerline communication technology.

IRIS-RFID

Venture Round in 2009
IRIS-RFID is a private French company established in Paris in August 2007. Their founding engineers have more than 40 years experience in total in the development and implementation of innovative RFID solutions internationally (Canada, United States, Brazil, France, Asia, Africa, etc.).

Augure

Series D in 2008
Augure, founded in 2002 in Paris, specializes in influencer marketing software that aids brands and agencies in integrating traditional public relations with modern influencer strategies. The platform is utilized by over 1,000 communication, PR, and public affairs teams daily, enabling them to engage relevant influencers, manage campaigns, and enhance their media presence and reputation across social networks. Augure's data services team complements its software offerings by providing consulting support, helping clients interpret data to refine their influencer marketing approaches. The company operates in Europe and Latin America, serving a diverse clientele that includes major organizations such as Orange, Thales, and Château de Versailles.

Seadev-FermenSys

Venture Round in 2007
Seadev-FermenSys is the exclusive operator of extremophile marine bacteria collections including IFREMER marine hydrothermophilic strains commercialized under an exclusive Trade License.

Carlipa Systems

Series C in 2007
Carlipa Systems offers automated multimedia communication solutions. The company’s products include Kast Engine©, a software engine for real time diffusion and NMG ® that allows automatic control of video and audio flows. These products are used for marketing of point of sale and television of company. Carlipa Systems was founded in 2002 and is based in Saint Nom la Bretèche, France.

Augure

Series C in 2006
Augure, founded in 2002 in Paris, specializes in influencer marketing software that aids brands and agencies in integrating traditional public relations with modern influencer strategies. The platform is utilized by over 1,000 communication, PR, and public affairs teams daily, enabling them to engage relevant influencers, manage campaigns, and enhance their media presence and reputation across social networks. Augure's data services team complements its software offerings by providing consulting support, helping clients interpret data to refine their influencer marketing approaches. The company operates in Europe and Latin America, serving a diverse clientele that includes major organizations such as Orange, Thales, and Château de Versailles.

Carlipa Systems

Series B in 2005
Carlipa Systems offers automated multimedia communication solutions. The company’s products include Kast Engine©, a software engine for real time diffusion and NMG ® that allows automatic control of video and audio flows. These products are used for marketing of point of sale and television of company. Carlipa Systems was founded in 2002 and is based in Saint Nom la Bretèche, France.